ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study

BACKGROUND: Sarcoid tumors are common in horses and may negatively impact the performance and value of the horse. No known treatment is reliably successful. HYPOTHESES/OBJECTIVES: To determine tolerability, overall response rate, time to response, and progression‐free survival of horses with biopsy‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Saba, Corey, Eggleston, Randall, Parks, Andrew, Peroni, John, Sjoberg, Eric, Rice, Shelbe, Tyma, Jesse, Williams, Jarred, Grosenbaugh, Deborah, Leard, A. Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
EQUINE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151478/
https://www.ncbi.nlm.nih.gov/pubmed/35416353
http://dx.doi.org/10.1111/jvim.16425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151478/
https://www.ncbi.nlm.nih.gov/pubmed/35416353
http://dx.doi.org/10.1111/jvim.16425

Ejemplares similares